RBC Capital cuts Amgen stock price target to $320 from $324 - MSN

On Wednesday, RBC Capital Markets adjusted its price target for Amgen (NASDAQ:AMGN) shares, reducing it slightly from $324 to $320, while retaining an Outperform rating on the biotechnology firm's ...

CouponFollow Extension

$320
OFF

RBC Capital Cuts Amgen Stock Price Target To $320 From $324 - MSN

2 weeks from now

msn.com

$320
OFF

RBC Capital Cuts Amgen Stock Price Target To $320 From $324

2 weeks from now

3 days ago · On Wednesday, RBC Capital Markets adjusted its price target for Amgen (NASDAQ: AMGN) shares, reducing it slightly from $324 to $320, while retaining an Outperform rating on …

investing.com

$320
OFF

RBC Trims Price Target On Amgen To $320 From $324, Keeps …

2 weeks from now

2 days ago · RBC Trims Price Target on Amgen to $320 From $324, Keeps Outperform Rating 07:40am: MT Morgan Stanley Lifts Price Target on Amgen to $328 From $322, Keeps …

marketscreener.com

$324
OFF

Amgen Price Target Lowered To $324 From $330 At RBC Capital

2 weeks from now

Jan 7, 2025 · RBC Capital lowered the firm’s price target on Amgen (AMGN) to $324 from $330 and keeps an Outperform rating on the shares as part of a broader research note previewing …

nasdaq.com

$324
OFF

Amgen Stock Price Target Cut, Holds Outperform On Prospects

2 weeks from now

Jan 7, 2025 · On Tuesday, RBC (TSX:RY) Capital Markets adjusted its price target on Amgen (NASDAQ:AMGN) shares, reducing it to $324 from the previous $330, while maintaining an …

investing.com

$320
OFF

RBC Capital Cuts Amgen Stock Price Target To $320 From $324

2 weeks from now

3 days ago · On Wednesday, RBC (TSX: RY) Capital Markets adjusted its price target for Amgen (NASDAQ: AMGN) shares, reducing it slightly from $324 to $320, while retaining an …

investing.com

$320
OFF

RBC Capital Cuts Amgen Stock Price Target To $320 From $324

2 weeks from now

3 days ago · On Wednesday, RBC Capital Markets adjusted its price target for Amgen (NASDAQ: AMGN) shares, reducing it slightly from $324 to $320, while retaining an Outperform rating on …

investing.com

$320.00
OFF

Amgen (AMGN) Gets A Buy From RBC Capital | Markets Insider

2 weeks from now

3 days ago · RBC Capital analyst Gregory Renza maintained a Buy rating on Amgen (AMGN – Research Report) yesterday and set a price target of $320.00. The company’s shares closed …

businessinsider.com

$324
OFF

Erste Group Lifts Amgen Stock Rating To Buy On Strong Margins

2 weeks from now

In other recent news, Amgen has been the subject of various analyst updates and developments. RBC Capital revised its price target for Amgen's stock from $324 to $320, maintaining an …

msn.com

$330
OFF

Amgen Stock Slips After More Analyst Criticism On Weight

2 weeks from now

Nov 27, 2024 · RBC Capital analyst Gregory Renza reduced his price target for Amgen to $330 from $360, maintaining an ‘Outperform’ rating. Renza noted that while the drug’s efficacy …

stocktwits.com

$324
OFF

Amgen Stock Price Target Cut, Holds Outperform On Prospects

2 weeks from now

Jan 7, 2025 · On Tuesday, RBC Capital Markets adjusted its price target on Amgen (NASDAQ: AMGN) shares, reducing it to $324 from the previous $330, while maintaining an Outperform …

investing.com

$324.00
OFF

Amgen (AMGN) Receives A Buy From RBC Capital - Markets Insider

2 weeks from now

Jan 24, 2025 · In a report released today, Gregory Renza from RBC Capital maintained a Buy rating on Amgen (AMGN – Research Report), with a price target of $324.00. The company’s …

businessinsider.com

$324
OFF

Amgen Stock Price Target Cut, Holds Outperform On Prospects

2 weeks from now

Jan 7, 2025 · On Tuesday, RBC Capital Markets adjusted its price target on Amgen (NASDAQ: AMGN) shares, reducing it to $324 from the previous $330, while maintaining an Outperform …

investing.com

$324
OFF

Amgen Price Target Lowered To $324 From $330 At RBC Capital

2 weeks from now

Jan 7, 2025 · RBC Capital lowered the firm’s price target on Amgen (AMGN) to $324 from $330 and keeps an Outperform rating on the shares as part of a broader ...

businessinsider.com

$483807
OFF

Amgen SVP Nancy Grygiel Sells Stock For $483,807 - MSN

2 weeks from now

Meanwhile, RBC Capital Markets adjusted its price target for Amgen shares from $324 to $320, maintaining an Outperform rating. The firm highlighted Amgen's robust Q4 performance and …

msn.com

$320
OFF

RBC Trims Price Target On Amgen To $320 From $324, Keeps …

2 weeks from now

3 days ago · Amgen has an average rating of overweight and mean price target of $314.54, according to analysts polled by FactSet. ...

marketscreener.com

$320
OFF

RBC Capital Cuts Amgen Stock Price Target To $320 From $324

2 weeks from now

3 days ago · On Wednesday, RBC Capital Markets adjusted its price target for Amgen (NASDAQ: AMGN) shares, reducing it slightly from $324 to $320, while retaining an Outperform rating on …

investing.com

$330
OFF

Amgen Price Target Lowered To $330 From $360 At RBC Capital

2 weeks from now

Nov 27, 2024 · RBC Capital analyst Gregory Renza lowered the firm’s price target on Amgen to $330 from $360 and keeps an Outperform rating on the shares.The company’s MariTide’s …

tipranks.com

$483807
OFF

Amgen SVP Nancy Grygiel Sells Stock For $483,807 - Investing.com

2 weeks from now

Meanwhile, RBC Capital Markets adjusted its price target for Amgen shares from $324 to $320, maintaining an Outperform rating. The firm highlighted Amgen's robust Q4 performance and …

investing.com

$280.30
OFF

Amgen (AMGN) Stock Forecast And Price Target 2025 - MarketBeat

2 weeks from now

5 days ago · The current stock price is $280.30, which is well below its 12-month high of $346.85, potentially offering a buying opportunity for investors looking for growth. Analysts have a …

marketbeat.com

$324
OFF

RBC Capital Reiterates Outperform On Amgen, Maintains $324 …

2 weeks from now

Jan 24, 2025 · RBC Capital analyst Gregory Renza reiterates Amgen (NASDAQ:AMGN) with a Outperform and maintains $324 price target.

sahmcapital.com

FAQs about RBC Capital cuts Amgen stock price target to $320 from $324 - MSN Coupon?

How much does Amgen stock cost?

According to the research reports of 27 Wall Street equities research analysts, the average twelve-month stock price forecast for Amgen is $314.00, with a high forecast of $405.00 and a low forecast of $195.00. Should I buy or sell Amgen stock right now? ...

Why did Erste Group Upgrade Amgen shares from hold to buy?

On Wednesday, Erste Group upgraded shares of biotechnology firm Amgen (NASDAQ:AMGN) from Hold to Buy. The upgrade was primarily attributed to Amgen's financial performance, which includes a higher operating margin and impressive 56% return on equity. ...

Should you buy Amgen (Amgen)?

Amgen's upgraded status to Buy reflects a confidence in the company's ability to outperform within this competitive landscape. Investors may consider the upgrade by Erste Group as a noteworthy development for Amgen as the market continues to assess the value and performance of biotechnology stocks. ...

Should you invest in Amgen Inc?

Investors should be bearish about investing in Amgen Inc. for these reasons: Amgen Inc. has a high debt-to-equity ratio of 7.55, which may indicate financial risk as it suggests the company relies heavily on debt financing compared to equity. ...